Related Experiment Video
Updated: Sep 10, 2025

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
Published on: March 7, 2025
Redefining Chemoresistance: Natural Bioactives as Molecular Modulators at the Cancer-Tumor Microenvironment Interface
Claudia Reytor-González1, Emilia Jiménez-Flores1, Natalí González2
1Universidad UTE, Facultad de Ciencias de la Salud Eugenio Espejo, Centro de Investigación en Salud Pública y Epidemiología Clínica (CISPEC), Quito 170527, Ecuador.
Abstract:
Therapeutic resistance remains a critical barrier in effective cancer treatment, contributing to disease recurrence, progression, and reduced patient survival. In recent years, natural bioactive compounds have emerged as promising adjuncts in oncology due to their ability to modulate multiple biological processes involved in resistance. This review explores current evidence on the role of natural compounds in influencing cancer cell behavior and their interactions with the tumor microenvironment. By organizing these compounds into chemical families, we provide a structured overview of their potential to enhance the efficacy of standard chemotherapy and reduce resistance-related mechanisms. We also highlight innovative strategies, including combination therapies and advanced drug delivery systems, that aim to improve their clinical applicability. Overall, this work underscores the relevance of integrating natural bioactives into modern cancer therapy and calls for further translational research to bridge preclinical findings with clinical implementation.
Insights
Natural compounds show promise in overcoming cancer therapeutic resistance by modulating cancer cell behavior and the tumor microenvironment. Further research is needed to integrate these bioactives into clinical practice for improved cancer treatment outcomes.
Area of Science:
- Oncology
- Pharmacology
- Natural Products Chemistry
Background:
- Therapeutic resistance is a major challenge in cancer treatment, leading to poor patient outcomes.
- Natural bioactive compounds offer potential as adjuncts to overcome resistance by targeting multiple pathways.
- Understanding their mechanisms and interactions within the tumor microenvironment is crucial.
Purpose of the Study:
- To review the current evidence on natural compounds' role in influencing cancer cell behavior and the tumor microenvironment.
- To provide a structured overview of natural compounds, organized by chemical families, for enhancing chemotherapy efficacy.
- To highlight strategies for improving the clinical applicability of natural compounds in cancer therapy.
Main Methods:
- Systematic review of preclinical and clinical studies on natural compounds and cancer resistance.
- Categorization of natural compounds into distinct chemical families.
- Analysis of their impact on cancer cell signaling, drug metabolism, and tumor microenvironment modulation.
- Exploration of combination therapies and novel drug delivery systems.
Main Results:
- Natural compounds modulate key cellular processes implicated in therapeutic resistance.
- Evidence suggests potential for enhancing standard chemotherapy efficacy and overcoming resistance mechanisms.
- Specific chemical families show promise in targeting cancer cell behavior and tumor microenvironment interactions.
- Combination therapies and advanced delivery systems are emerging strategies for clinical translation.
Conclusions:
- Natural bioactive compounds are relevant adjuncts for modern cancer therapy, offering multifaceted mechanisms to combat resistance.
- Translational research is essential to bridge promising preclinical findings with effective clinical implementation.
- Further investigation into combination strategies and delivery systems will enhance the therapeutic potential of natural compounds in oncology.
More Related Videos
08:26MAME Models for 4D Live-cell Imaging of Tumor: Microenvironment Interactions that Impact Malignant Progression
Published on: February 17, 2012
07:44Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports
Published on: November 28, 2019
Related Concept Videos
The Tumor Microenvironment
Targeted Cancer Therapies
There are several types of targeted therapies against...
Treatment Resistant Cancers
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Drugs that Stabilize Microtubules
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...